Trial Profile
Randomized, Double-blind Clinical Trial of the Use of Mirtazapine Versus Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2023
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary) ; Megestrol
- Indications Anorexia; Cachexia
- Focus Therapeutic Use
- 24 Apr 2022 Status changed from recruiting to completed.
- 03 May 2020 Planned number of patients changed from 52 to 40.
- 03 May 2020 Planned End Date changed from 30 Dec 2020 to 30 Dec 2021.